The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine Alhemo (concizumab) to prevent or ...

Indian drugmaker Cipla Limited has entered into a strategic marketing and distribution agreement with US pharma major Eli ...

US pharma major Eli Lilly shares closed up 2.8%, while those of Adverum Biotechnologies dropped 2.4% to $4.28, on news of a ...

UK regulators have dismantled a major illicit operation producing unlicensed weight loss medicines, following a raid on a ...

San Diego-based inflammatory diseases specialist Ventyx Biosciences announced positive results from its Phase II study of ...

French pharma major Sanofi (Euronext: SAN) reported third-quarter 2025 revenue of 12.4 billion euros ($13.2 billion), up 7% ...

The UK’s National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending the use of ...

French biotech Abolis Biotechnologies has signed a strategic partnership with EUROAPI (EPA: EAPI) to develop microbial ...

US healthcare giant Johnson & Johnson today announced that the European Commission (EC) has approved the expansion for the marketing authorization for Tremfya (guselkumab) to include a subcutaneous ...

US clinical-stage biotech Tango Therapeutics has announced the pricing of an underwritten offering of 21,023,337 shares of ...

US biotech major Biogen and Chicago, Canada-based Vanqua Bio today announced a license agreement granting Biogen exclusive ...

Japan’s Mitsubishi Tanabe Pharma (MTPC) yesterday announced that the US Food and Drug Administration (FDA) has issued a ...